• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Pharmacotherapy following myocardial infarction].

作者信息

Spinarová L, Spinar J, Vítovec J

机构信息

I. interní kardio-angjologická klinika Lékarské fakulty MU a FN u sv. Anny Brno.

出版信息

Vnitr Lek. 2011 Nov;57(11):966-9.

PMID:22165705
Abstract

Early reperfusion is the treatment of choice for acute coronary syndrome. In the Czech Republic, reperfusion therapy is well accessible thanks to the network of 22 catheterization centres. Every year, 28,000 patients are treated using this technique. Successful reperfusion should be followed by life style changes--smoking cessation, maintenance of appropriate body weight etc. These steps than has to be accompanied by effective pharmacotherapy to prevent remodelling of the left ventricle, re-stenosis of the coronary artery, re-thrombosis and arrhythmias. Four drug groups provide the desired effects--renin-angiotensin-aldosterone system blockers, beta-blockers, antiplatelet agents and statins.

摘要

相似文献

1
[Pharmacotherapy following myocardial infarction].
Vnitr Lek. 2011 Nov;57(11):966-9.
2
Optimal medical management of peripheral arterial disease.外周动脉疾病的优化医疗管理
Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. doi: 10.1177/1538574406291835.
3
The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry.捷克共和国不同医院类型“再灌注网络”中急性冠脉综合征的发病率、治疗策略及转归:捷克住院患者急性冠脉综合征评估(CZECH)注册研究结果
Int J Cardiol. 2007 Jul 10;119(2):212-9. doi: 10.1016/j.ijcard.2007.02.036. Epub 2007 Apr 18.
4
Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.急性缺血性冠状动脉疾病与缺血性卒中:异同点
Am J Ther. 2008 Mar-Apr;15(2):137-49. doi: 10.1097/MJT.0b013e31816a61bb.
5
[The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].[除抗血栓和抗血小板药物外,其他药物在非ST段抬高型急性冠状动脉综合征治疗中的应用]
Anadolu Kardiyol Derg. 2006 Apr;6 Suppl 1:30-4.
6
[Ambulatory management of patients after myocardial infarction].[心肌梗死后患者的门诊管理]
Rev Med Suisse Romande. 2000 Feb;120(2):159-66.
7
[Choosing the right medication for the right patient].
Rev Prat. 2005 Oct 31;55(16):1805-11.
8
Re: Secondary medical prevention in patients with peripheral arterial disease.关于:外周动脉疾病患者的二级医学预防
Eur J Vasc Endovasc Surg. 2008 Jan;35(1):59-60. doi: 10.1016/j.ejvs.2007.07.006. Epub 2007 Aug 27.
9
Potential novel pharmacological therapies for myocardial remodelling.针对心肌重塑的潜在新型药物疗法。
Cardiovasc Res. 2009 Feb 15;81(3):519-27. doi: 10.1093/cvr/cvn317. Epub 2008 Nov 19.
10
Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.法国心肌梗死后的循证药物治疗:与依从性相关的因素及其与 30 个月死亡率和再住院的关系。
Arch Cardiovasc Dis. 2010 Jun-Jul;103(6-7):363-75. doi: 10.1016/j.acvd.2010.05.003. Epub 2010 Jul 22.

引用本文的文献

1
Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.血管紧张素转换酶抑制剂、血管紧张素 II 受体拮抗剂及血管紧张素受体阻断剂/中性肽链内切酶抑制剂在心力衰竭患者中的应用:捷克共和国一项基于全国人口研究的亚组分析
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022 Sep;166(3):322-327. doi: 10.5507/bp.2021.035. Epub 2021 Jun 4.